Abstract:Background. Long noncoding RNAs (lncRNAs) often facilitate cellular communication via exosomes. However, their specific roles in head and neck squamous cell carcinoma (HNSCC) are not well understood. Methods. We extracted data on exosome‐related lncRNAs from exoRBase and collected transcriptional profiles and clinical details for HNSCC from the TCGA database. Data preprocessing and analyses incorporated Tumor Mutation Burden and Microsatellite Instability from Researcher's Home and drug sensitivity information from Genomics of Drug Sensitivity in Cancer database. We developed a prognostic model using Cox regression and LASSO regression analysis, with subsequent multivariate analysis to identify significant prognostic indicators. We also constructed a nomogram to evaluate the model's clinical relevance, performed Gene Set Enrichment Analysis (GSEA), and analyzed the immune microenvironment and therapy sensitivity using CIBERSORT and TIDE algorithms. Supporting in vitro experiments and statistical analyses were conducted. Results. Our comprehensive investigation revealed 17 exosome‐associated lncRNAs critical for patient survival in HNSCC. This enabled the development of a prognostic model that effectively stratifies patients into high‐risk and low‐risk categories. These lncRNAs correlate with patient demographics and clinical characteristics such as age, gender, and tumor stage. GSEA highlighted significant gene expression differences between the risk groups, particularly in pathways related to muscle formation, cellular transition, and immune response. The analysis of the immune microenvironment showed distinct immune cell infiltration patterns in high‐risk patients, indicative of compromised immune defenses. In addition, we explored the expression of critical immune checkpoints and their impact on immunotherapy efficacy, demonstrating that risk scores may predict treatment responses. Notably, LINC01564 was overexpressed in HNSCC, associated with poorer prognosis, enhanced xenobiotic metabolism, and altered immune cell infiltration. Experimental validation confirmed LINC01564's role in promoting tumor cell proliferation, invasion, and migration, highlighting its therapeutic potential. Conclusions. Our study highlights the importance of exosome‐associated lncRNAs in HNSCC, identifying 17 critical lncRNAs as vital prognostic markers. The upregulation of LINC01564, associated with poor outcomes and increased tumor aggressiveness, underscores its potential as a therapeutic target.

Exosomes in Head and Neck Squamous Cell Carcinoma

Exosomes, Microvesicles, And Head And Neck Cancers

Exosomes in head and neck cancer: Roles, mechanisms and applications

Exosome: Emerging Biomarker in Breast Cancer

Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma

The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma

The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers

Small Extracellular Vesicles in the Development, Diagnosis, and Possible Therapeutic Application of Esophageal Squamous Cell Carcinoma

Exosomes in Nasopharyngeal Carcinoma

The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application

The Emerging Role of Exosomes in Oral Squamous Cell Carcinoma

Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle

Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence

Exosomes: Isolation, Analysis, and Applications in Cancer Detection and Therapy.

Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application

Exosomes and cancer immunotherapy: A review of recent cancer research

Exosomes: Diagnostic and Therapeutic Implications in Cancer

The Role of Exosomes and Their Applications in Cancer

Tumor-derived exosomes in cancer progression and treatment failure

Exosomes in cancer: Small transporters with big functions

A Comprehensive Analysis of Exosome‐Related Long Noncoding RNAs as Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma